Seiji Hokimoto

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention

Kenichi Tsujita, Seigo Sugiyama, Hitoshi Sumida et al. · Journal of the American College of Cardiology · 2015 · 451 citations

Medicine, Cardiology, Pharmacology +16

High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)

Isao Taguchi, Satoshi Iimuro, Hiroshi Iwata et al. · Circulation · 2018 · 242 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes

Junichi Matsubara, Seigo Sugiyama, Eiichi Akiyama et al. · Circulation Journal · 2013 · 199 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction

Seiji Hokimoto, Koichi Kaikita, Satoshi Yasuda et al. · Circulation Journal · 2023 · 186 citations · Full text

Medicine, Cardiology, Clinical Sciences +17

Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel Blockers

Hirofumi Yasue, Yuji Mizuno, Eisaku Harada et al. · Journal of the American College of Cardiology · 2008 · 177 citations

Medicine, Cardiology, Pharmacology +11